Financials
- Market Capitalization 45.68 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.werewolftx.com
- Headquarter Delaware, United States
- FIGI BBG00QXQ9XK4
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.48
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4292 | CELU Celularity Inc. - Class A Common Stock | 1.57 USD | -25.24% | +103.90% | +109.33% | -59.11% | 45.45 M USD | ||
| 4293 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.20 USD | -0.83% | -2.44% | -0.83% | -16.67% | 45.33 M USD | ||
| 4298 | EDSA Edesa Biotech, Inc. - Common Shares | 4.55 USD | -1.09% | +2.71% | -8.82% | +87.24% | 43.87 M USD | ||
| 4301 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.13 USD | -1.39% | -3.18% | -3.18% | -46.48% | 44.81 M USD |